IMPLEMENTATION OF GOOD PRACTICES FOR ADMINISTERING VASOACTIVE AMINES: A QUASI-EXPERIMENTAL STUDY

• Autor(a) principal: Camerini,Flavia Giron
• Data de Publicação: 2022
• Outros Autores: Silva,Jaqueline Oliveira da, Henrique,Daniele Mendonça, Fassarella,Cintia Silva, Andrade,Karla Biancha Silva, Schutz,Vivian
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Texto & contexto enfermagem (Online)
• Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-07072022000100358
• topic: Patient safety; Cardiovascular drugs; Risk management; Nursing care; Medication systems in the hospital; Safety measures; Drug-related side effects and adverse reactions

ABSTRACT Objective to analyze the implementation of training on good practices for administering vasoactive amines when facing undesirable clinical events in patients of a cardiointensive unit. Method this is a quasi-experimental study (before and after), carried out in three stages at a university hospital located in Rio de Janeiro, Brazil. An observation was performed in the first stage about the team’s adherence to good practices in administering vasoactive amines. Training was conducted with the nursing team in the second stage to implement the actions, and adherence to good practices in administering vasoactive amines was evaluated in the third stage. Data collection was performed from October 2019 to July 2021. The McNemar test and the Wilcoxon non-parametric test were used to compare the differences in the pre- and post-intervention groups. Results a total of 280 patients were infused with vasoactive amines, 97 in the first stage (pre-intervention) and 183 after the intervention. The variables related to the administration in an exclusive way and the identification of the infusion pump obtained 100% assertiveness. A total of 37 (13.2%) undesirable clinical events related to the use of vasoactive amines were identified, 27 (27.8%) in the control group (pre-intervention) and 10 (5.5%) after the intervention, evidencing a significant reduction (p-value = 0.0001). Conclusion the implementation of the intervention significantly contributed to reducing the occurrence of undesirable clinical events related to administering vasoactive amines, contributing to safer drug therapy.